 |
 |

Epidemiological Features and Prognostic Factors of Cutaneous Head and Neck MelanomaA Population-Based Study
Alexander Golger, MD;
Diana S. Young, BSc;
Danny Ghazarian, PhD;
Peter C. Neligan, MB
Arch Otolaryngol Head Neck Surg. 2007;133(5):442-447.
Objectives To describe the epidemiological features of cutaneous head and neck melanoma (CHNM) and to identify factors associated with mortality from this disease.
Design A population-based cohort study.
Setting Patients treated for CHNM in Ontario between January 1, 1994, and December 31, 2002, were identified through the provincial Cancer Registry. A Cox proportional hazards regression model was used to analyze the data.
Patients A total of 2218 patients with CHNM were identified, comprising 15.8% of all melanomas in Ontario. The mean age of the cohort was 66 years (SD, 16 years); 1363 patients (61.5%) were males.
Main Outcome Measure Patients' vital status (dead or alive).
Results The incidence of CHNM increased from 2.0 per 100 000 in 1996 to 2.7 per 100 000 in 2001, while mortality remained stable. The Cox proportional hazards regression model showed that increased age (hazard ratio [HR], 1.06; 95% confidence interval [CI], 1.04-1.06) and male sex (HR, 1.31; 95% CI, 1.03-1.66) had a significantly higher risk of death. Patients with lesions of the scalp and neck had a 53% higher risk of death than those with lesions of the face. Nodular melanoma (HR, 1.61; 95% CI, 1.17-2.24) had the worst prognosis compared with other morphological types. Increased tumor thickness (HR, 1.05; 95% CI, 1.03-1.07), ulceration (HR, 1.53; 95% CI, 1.08-2.07), and Clark level V (HR, 1.52; 95% CI, 1.01-2.22) were significantly associated with increased mortality.
Conclusions Our study demonstrated an increase in the incidence of CHNM. Advanced age, male sex, nodular morphological features, tumor thickness, ulceration, and Clark level V carried a significant risk of death, whereas facial melanomas had a favorable prognosis.
Author Affiliations: Division of Plastic Surgery, Department of Surgery, University of Toronto (Drs Golger and Neligan and Ms Young), and Department of Pathology, Princess Margaret Hospital, University Health Network (Dr Ghazarian), Toronto, Ontario.
RELATED ARTICLE
Incidence and Prognosis of Cutaneous Melanoma Involving the Head and Neck
Carol R. Bradford and Paul A. Levine
JAMA. 2007;297(23):2628-2629.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Survival Differences Between Patients With Scalp or Neck Melanoma and Those With Melanoma of Other Sites in the Surveillance, Epidemiology, and End Results (SEER) Program
Lachiewicz et al.
Arch Dermatol 2008;144:515-521.
ABSTRACT
| FULL TEXT
Incidence and Prognosis of Cutaneous Melanoma Involving the Head and Neck
Bradford and Levine
JAMA 2007;297:2628-2629.
FULL TEXT
|